📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Dual G9A/EZH2 Inhibition Stimulates Antitumor Immune Response in Ovarian High-Grade Serous Carcinoma (2022)

First Author: Spiliopoulou P

Attributed to: Imperial College London – Confidence in Concept 2019 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/1535-7163.mct-21-0743

PubMed Identifier: 35131874

Publication URI: http://europepmc.org/abstract/MED/35131874

Type: Journal Article/Review

Parent Publication: Molecular Cancer Therapeutics

Issue: 4

ISSN: 1535-7163